#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dedifferentiated liposarcoma Diffuse large B-cell lymphoma Anal cancer Uveitis Staphylococcal infection Synovitis Synovial sarcoma recurrent Hypertriglyceridaemia Extranodal marginal zone B-cell lymphoma (MALT type) Arrhythmogenic right ventricular dysplasia Peritoneal mesothelioma malignant Acute myeloid leukaemia recurrent Hereditary spastic paraplegia Round cell liposarcoma Measles More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Basic Information Ornithine transcarbamoylase deficiency – Diagnostics Adrenocortical carcinoma – Basic Information Wolfram syndrome Andersen-Tawil syndrome – Treatment Gaucher’s disease type I Rhabdoid tumour – Trials in Disease Aicardi-Goutieres syndrome – Life with Disease Methylmalonic acidaemia Angelman’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naloxone Hydrochloride HYPOCHLOROUS ACID Buloxibutid Quinapril Hydrochloride Phleum Pratense Pollen Extract Ifosfamide Carfilzomib Gefitinib Atomoxetine Hydrochloride Elritercept Xenon (129Xe) IMA401 Tezepelumab Mitapivat IHMA-2121771-2 Alnuctamab Prasugrel Hydrobromide Darolutamide Triptorelin Acetate Toripalimab More therapies…

    Learn about Your Condition

    Autoimmune hepatitis Tubulointerstitial nephritis Thromboembolectomy Oesophagectomy Blood disorder Meningococcal infection Systemic infection Haemodynamic instability Breast angiosarcoma Thyroid disorder Atrial fibrillation Cough Ehlers-Danlos syndrome Micrographic skin surgery Depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Metronomic Chemotherapy for Children and Teenagers with Relapsed or Refractory Wilms Tumor Using Vincristine, Irinotecan, Etoposide, Temozolomide, and Isotretinoin

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Isotretinoin
    • Vinblastine Sulfate
    • Etoposide
    France

  • Study on Pain Relief for Limb Injuries in Children: Comparing Intranasal Fentanyl, Intranasal Ketamine, and Oral Morphine in Patients Aged 2-17 Years

    Recruiting

    4 1 1
    Investigated Drugs:
    • Morphine Sulfate
    • Ketamine
    • Fentanyl Citrate
    France

  • Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Juvenile chronic myelomonocytic leukaemia
    • Philadelphia positive chronic myeloid leukaemia
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib
    • Asciminib Hydrochloride
    France Germany Greece Hungary Italy The Netherlands +1

  • Study Comparing Methylprednisolone Aceponate Creams and a Non-Active Cream for Patients with Mild to Moderate Atopic Dermatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Methylprednisolone Aceponate
    Germany

  • Study on Atezolizumab, Bevacizumab, and EXL01 for Patients with Liver Cancer Not Responding to First-Line Immunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Exl01
    • Atezolizumab
    • Bevacizumab
    France

  • Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    France
Previous Page
1 … 493 494 495 496 497 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!